永安药业：部分董事、高级管理人员计划减持公司股份不超过约24万股

Company Summary - Yong'an Pharmaceutical (SZ 002365) announced that several directors and senior management, including Hong Rengui, Fang Xiquan, Wang Zhihua, Xiong Shengjie, and Li Shaobo, plan to reduce their holdings by up to approximately 240,000 shares within three months, which represents 0.0799% of the total share capital [1] - The company’s current market capitalization is 5.1 billion yuan [1] Revenue Composition - For the first half of 2025, Yong'an Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 64.14%, health food for 24.67%, chemical manufacturing for 10.88%, and other businesses for 0.32% [1]